Results 211 to 220 of about 4,625 (266)
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
A Novel Arithmetic Optimization PDR Algorithm for Smartphones. [PDF]
Zhang M, Xu A.
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
RECORD: A Simple, Low-Cost, and Open-Source IMU-Based Tool for the Diagnosis of Body Schema Distortions. [PDF]
Marechal L +5 more
europepmc +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Low-Cost Optical-Inertial Point Cloud Acquisition and Sketch System. [PDF]
Chao TC, Shih HF, Tien CL, Tu HY.
europepmc +1 more source
Finding novel vulnerabilities of hypomorphic BRCA1 alleles
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder +10 more
wiley +1 more source
An Integrated Low-Cost Underwater Navigation Solution for Divers Employing an INS Composed of Low-Cost Sensors Using the Robust Kalman Filter and Sensor Fusion. [PDF]
Hayashi T, Terada D.
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Corrigendum to "Enhancing climate resilience: A data-driven north rift weather prediction system for real-time forecasting and agricultural decision support" [Volume 11, Issue 4, 28 February 2025, e42549]. [PDF]
Makokha JW, Barasa PW, Khamala GW.
europepmc +1 more source

